---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-238450"
form_type: "8-K"
ticker: "SYBX"
cik: "0001527599"
company_name: "SYNLOGIC, INC."
filed_at: "2022-09-06T23:59:59+00:00"
generated_at: "2026-06-23T15:18:33.406676+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Synlogic achieves second research milestone under Roche IBD collaboration

## Summary
- Second pre-specified milestone earned; milestone payment triggered under Roche collaboration.
- First milestone was achieved and payment earned in September 2021.
- Collaboration Agreement signed June 2021; Roche has exclusive option to negotiate a license after research period.

## SEC filing metadata
- accession: 0001193125-22-238450
- form_type: 8-K
- ticker: SYBX
- cik: 0001527599
- company_name: SYNLOGIC, INC.
- filed_at: 2022-09-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527599/000119312522238450/0001193125-22-238450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527599/000119312522238450/d373052d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-238450
- JSON: https://secwatch.observer/filing/0001193125-22-238450.json
- Plain text: https://secwatch.observer/filing/0001193125-22-238450.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.